ICLR Price Prediction Next Week
Based on the recent data and market analysis, here's the price prediction for ICLR for the next trading week:
Technical Analysis
The stock is currently showing bearish signals with RSI at 37.57, indicating oversold conditions. The MACD is at -3.80, suggesting continued downward momentum. The stock is trading significantly below its 200-day SMA of $277.14 and 20-day SMA of $205.87, indicating a strong bearish trend.
Price Levels Analysis Key Fibonacci levels for the week:
- Resistance 1: $205.41
- Resistance 2: $208.64
- Resistance 3: $213.86
- Support 1: $194.96
- Support 2: $191.73
- Support 3: $186.51
- Pivot: $200.18
News Impact Recent negative catalysts include:
- FY25 guidance below market expectations
- Stock fell 9.22% after issuing guidance with midpoint below estimates
- Insider sentiment is negative with increased selling activity
Positive Factors
- Strong analyst support with Buy ratings:
- Evercore ISI: $240 price target
- Bank of America: $270 price target
- Barclays: $275 price target
Price Prediction for Next Week Based on technical indicators and recent news:
- Bearish Scenario (60% probability): Stock likely to test support at $191.73-$194.96
- Base Scenario (30% probability): Consolidation between $195-$205
- Bullish Scenario (10% probability): Bounce to resistance at $205.41
Expected trading range: $191.73-$205.41 Most likely price target: $193-$195
Recommendation: SELL The combination of negative technical indicators, below-consensus guidance, and negative insider sentiment suggests further downside potential in the near term, despite positive analyst ratings.
ICLR Similar Chart Price Prediction
The price of ICLR is predicted to go up 30.77%, based on the high correlation periods with BNED. The similarity of these two price pattern on the periods is 95.78%.
ICLR
BNED
Up: 30.77%Similarity: 95.78%
ICLR Revenue Forecast
ICLR EPS Forecast
ICLR FAQs
What is bull’s view on ICLR?
What is bear's view on ICLR?
What is ICLR revenue forecast for next quarter？
What is ICLR eps forecast for next quarter？
ICLR VS S&P500
Icon is highly exposed to the late-stage CRO industry, which due to its complexity is conducive to long-term competitive advantages.
The company's operational discipline should support strong earnings growth and high returns as Icon expands.
As an Irish company, Icon benefits from a lower tax rate than many of its peers based in the United States.
ICLR Analyst's Forecast
Patrick Donnelly
Citigroup
Strong Buy
Price Target
$300 → $290
Upside
+34.56%
Citi lowered the firm's price target on Icon to $290 from $300 and keeps a Buy rating on the shares. Outside of the preannouncements and guidance updates from life science tools and diagnostics names in January, Citi expects key themes to include the cadence and magnitude of the expected recoveries in areas such as China and bioprocessing, the rollout of the China stimulus program, trends within the instrumentation replacement cycle, general biopharma health and its possible impact on clinical trial demand, and the possible effects of the new administration. The firm adjusted numbers for Icon to reflect lower margins given the pass-through impact.
Eric Coldwell
Baird
Hold
Price Target
$249 → $225
Upside
+10.47%
Jailendra Singh
Truist Securities
Strong Buy
Price Target
$363 → $295
Upside
+27.98%